Published in FEBS Lett on October 15, 1977
Subunit dissociations in natural and recombinant hemoglobins. Protein Sci (1996) 1.07
Energetic differences at the subunit interfaces of normal human hemoglobins correlate with their developmental profile. Biochemistry (2009) 0.85
Developmental expression of human hemoglobins mediated by maturation of their subunit interfaces. Protein Sci (2010) 0.80
The measurement of the intrinsic alkaline Bohr effect of various human haemoglobins by isoelectric focusing. Biochem J (1981) 0.75
Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proc Natl Acad Sci U S A (1984) 2.86
Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J Biol Chem (1995) 2.69
Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia. Br J Haematol (1990) 2.02
Alteplase for hepatic veno-occlusive disease complicating bone-marrow transplantation. Lancet (1992) 1.99
Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. N Engl J Med (1985) 1.90
Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients. Proc Natl Acad Sci U S A (1985) 1.85
MgcRacGAP, a new human GTPase-activating protein for Rac and Cdc42 similar to Drosophila rotundRacGAP gene product, is expressed in male germ cells. J Biol Chem (1998) 1.56
Preliminary report on the use of desferrioxamine in the treatment of Plasmodium falciparum malaria. Am J Hematol (1991) 1.54
Priapism following splenectomy in an unstable hemoglobin: hemoglobin Olmsted beta 141 (H19) Leu-->Arg. Am J Hematol (1996) 1.52
Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S. Proc Natl Acad Sci U S A (1979) 1.50
Reversible inhibitory effects and absence of toxicity of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in human long-term bone marrow culture. Exp Hematol (1992) 1.49
Structural analysis of the 5' flanking region of the beta-globin gene in African sickle cell anemia patients: further evidence for three origins of the sickle cell mutation in Africa. Proc Natl Acad Sci U S A (1988) 1.43
The -158 site 5' to the G gamma gene and G gamma expression. Blood (1985) 1.34
Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia (2003) 1.29
The hematologic characteristics of sickle cell anemia bearing the Bantu haplotype: the relationship between G gamma and HbF level. Blood (1987) 1.29
A novel sickle cell mutation of yet another origin in Africa: the Cameroon type. Hum Genet (1992) 1.23
Haplotypes in tribal Indians bearing the sickle gene: evidence for the unicentric origin of the beta S mutation and the unicentric origin of the tribal populations of India. Hum Biol (1989) 1.23
Cation-exchange HPLC evaluated for presumptive identification of hemoglobin variants. Clin Chem (1997) 1.19
Characterization and functional analysis of adult human bone marrow cell subsets in relation to B-lymphoid development. Blood (1993) 1.15
Beta-chain contact sites in the haemoglobin S polymer. Nature (1980) 1.13
Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer (1986) 1.12
ADP-ribosylation of the ras-related, GTP-binding protein RhoA inhibits lymphocyte-mediated cytotoxicity. J Biol Chem (1992) 1.12
Covalent structures of beta and gamma autolytic derivatives of human alpha-thrombin. J Biol Chem (1984) 1.11
DNA sequence variation in a negative control region 5' to the beta-globin gene correlates with the phenotypic expression of the beta s mutation. Blood (1992) 1.08
Origin and spread of beta-globin gene mutations in India, Africa, and Mediterranea: analysis of the 5' flanking and intragenic sequences of beta S and beta C genes. Hum Biol (1991) 1.08
Importation route of the sickle cell trait into Portugal: contribution of molecular epidemiology. Hum Biol (1992) 1.07
The sickle gene polymorphism in North Africa. Blood (1981) 1.06
Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures. J Clin Microbiol (1996) 1.06
Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease. J Pediatr Hematol Oncol (1997) 1.06
Megakaryoblastic acute leukemia: identification by the ultrastructural demonstration of platelet peroxidase. Blood (1978) 1.06
Sickle gene. Its origin and diffusion from West Africa. J Clin Invest (1981) 1.06
Uniparental disomy: a novel mechanism for thalassemia major. Blood (1992) 1.05
Human erythrocyte band 3 polymorphism (band 3 Memphis): characterization of the structural modification (Lys 56----Glu) by protein chemistry methods. Blood (1991) 1.04
Absence of annulus in human asthenozoospermia: case report. Hum Reprod (2009) 1.04
Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5). Bone Marrow Transplant (1999) 1.02
Anthropological approach to the heterogeneity of beta-thalassemia mutations in northern Africa. Hum Biol (1994) 1.01
Enhanced apoptosis in the thymus of transgenic mice expressing constitutively activated forms of human Rac2GTPase. Oncogene (1997) 1.01
Inhibition of superoxide production in B lymphocytes by rac antisense oligonucleotides. J Biol Chem (1992) 1.00
The spectrum of beta-thalassaemia in Algeria: possible origins of the molecular heterogeneity and a tentative diagnostic strategy. Br J Haematol (1993) 1.00
Appearance of beta globin synthesis in erythroid cells of Ferrara beta -o-thalassaemic patients following blood transfusion. Nature (1975) 1.00
Molecular adaptation of hemoglobin function in mammals. Respir Physiol (1992) 0.99
Four new haplotypes observed in Algerian beta-thalassemia patients. Hum Genet (1983) 0.99
Databases of human hemoglobin variants and other resources at the globin gene server. Hemoglobin (2001) 0.98
patients with the description of a new scoring system and its validation on 253 other patients. Blood (2000) 0.98
Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Congo. Hum Hered (1998) 0.97
Fetal haemoglobin variations following hydroxyurea treatment in patients with cyanotic congenital heart disease. Nouv Rev Fr Hematol (1994) 0.96
Tat1, a novel sulfate transporter specifically expressed in human male germ cells and potentially linked to rhogtpase signaling. J Biol Chem (2001) 0.95
Impairment of the growth of Plasmodium falciparum in HbEE erythrocytes. J Clin Invest (1981) 0.95
High level of tyrosine protein kinase in a murine lymphoma cell line induced by Moloney leukemia virus. EMBO J (1982) 0.94
The Rac target NADPH oxidase p67phox interacts preferentially with Rac2 rather than Rac1. J Biol Chem (1996) 0.94
Phosphorylation sites in human erythrocyte band 3 protein. Biochim Biophys Acta (1991) 0.92
Glycosylated haemoglobin in patients on venesection therapy for haemochromatosis. Lancet (1980) 0.92
A hemopoietic specific gene encoding a small GTP binding protein is overexpressed during T cell activation. Biochem Biophys Res Commun (1991) 0.91
A novel beta thalassemia gene with a single base mutation in the conserved polypyrimidine sequence at the 3' end of IVS 2. Nucleic Acids Res (1988) 0.91
Influence of thyroid status on hemoglobin A2 expression. J Clin Endocrinol Metab (1983) 0.90
High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients. Eur J Cancer (1981) 0.89
Successful autologous bone marrow transplantation in second remission of malignant histiocytosis. Bone Marrow Transplant (1990) 0.89
Phosphorylations of the subcellular matrix in cells transformed by Rous' sarcoma virus. Eur J Biochem (1982) 0.89
Three regions of erythrocyte band 3 protein are phosphorylated on tyrosines: characterization of the phosphorylation sites by solid phase sequencing combined with capillary electrophoresis. Biochim Biophys Acta (1991) 0.88
Haemoglobinopathies and G.-6-P.D. deficiency in Laos. Lancet (1978) 0.88
Hemoglobins S and C in Upper Volta. Hum Genet (1984) 0.88
Two new hemoglobin variants with deletion. Hemoglobin tours: Thr 8 7 (F 3 ) deleted and hemoglobin St Antoine: Gly-Leu 74-75 (E 18-19 deleted. Consequences for oxygen affinity and protein stability. Biochim Biophys Acta (1973) 0.88
Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol (1986) 0.88
Hb Harrow [beta118(GH1)Phe-->Cys]: a new neutral hemoglobin variant. Hemoglobin (1999) 0.88
[Ectopic bone formation in neurological lesions (author's transl)]. Rev Chir Orthop Reparatrice Appar Mot (1979) 0.87
Investigation of the tetramer-dimer equilibrium in haemoglobin solutions by high-performance size-exclusion chromatography on a diol column. J Chromatogr (1988) 0.87
Isolation and functional characterization of hemoglobin Casper: beta106(G8) Leu replaced by Pro. Biochemistry (1975) 0.87
An insulinoma nuclear factor binding to GGGCCC motifs in human insulin gene. Nucleic Acids Res (1993) 0.87
Abnormal hemoglobin synthesis in some leukemic patients. Biochimie (1975) 0.86
Hb Setif: G1 (94) Asp-Tyr. A new chain hemoglobin variant with substitution of the residue involved in hydrogen bond between unlike subunits. FEBS Lett (1972) 0.86
[Non-Hodgkin's malignant lymphoma. Therapeutic value of autologous bone marrow transplantation]. Presse Med (1983) 0.86
A new hemoglobin variant altering the alpha 1 beta 2 contact: Hb Chemilly alpha 2 beta 2 99(G1)Asp leads to Val. FEBS Lett (1984) 0.85
Differences in DNase I sensitivity and methylation within the human beta-globin gene domain and correlation with expression. Eur J Biochem (1986) 0.85
RhoGAPs and RhoGDIs, (His)stories of two families. Prog Mol Subcell Biol (1999) 0.85
Hemoglobins in Togolese newborns: Hb S, Hb C, Hb Bart's, and alpha-globin gene status. Am J Hematol (1998) 0.85
Human liquid bone marrow culture in serum-free medium. Br J Haematol (1989) 0.85
An unusual case of leukemia with high fetal hemoglobin: demonstration of abnormal hemoglobin synthesis localized in a red cell clone. Blood (1977) 0.85
Beta S gene in Sicily is in linkage disequilibrium with the Benin haplotype: implications for gene flow. Am J Hematol (1988) 0.84
[Polycythemia resulting from abnormal hemoglobin with increased affinity for oxygen. Two cases (author's transl)]. Nouv Presse Med (1980) 0.84
High genetic polymorphism of hemoglobin disorders in Laos. Complex phenotypes due to associated thalassemic syndromes. Hum Genet (1979) 0.84
Molecular basis of beta-thalassemia in Bahrain: an epicenter for a Middle East specific mutation. Ann N Y Acad Sci (1998) 0.84
Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation. Eur J Haematol (1991) 0.84
The consequences and implications of the multicentric origin of the Hb S gene. Prog Clin Biol Res (1985) 0.84
Long-term hydroxyurea treatment in young sickle cell patients. Curr Opin Hematol (1999) 0.84
Two variants of hemoglobin D in the algerian population: hemoglobin D Ouled Rabah 19 (BI) Asn leads to Lys and hemoglobin D Iran 22 (Br) Glu leads to Gln. Biochim Biophys Acta (1973) 0.84